Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure
- 1 June 1999
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 276 (6) , H1935-H1942
- https://doi.org/10.1152/ajpheart.1999.276.6.h1935
Abstract
Natriuretic peptide (NP) receptor has been postulated to be downregulated under a high concentration of atrial NP (ANP) in congestive heart failure (CHF), but limited information is available on how the vascular functional responsiveness to NPs is altered in coronary circulation during CHF. We assessed the relaxant effects of ANP, brain NP (BNP), and other vasodilators in isolated coronary arteries obtained from dogs with and without severe CHF induced by rapid right ventricular pacing. In CHF dogs, plasma ANP and cGMP concentrations were elevated compared with control dogs. In CHF arteries the relaxant effects of ANP and BNP (10−8and 10−7mol/l) were suppressed compared with control arteries. Nitroglycerin, nitric oxide, 8-bromo-cGMP, and beraprost sodium produced similar concentration-response curves in both arteries. The addition of 10−7mol/l ANP increased the level of tissue cGMP in control arteries, but not in CHF arteries. We conclude that there was a specific reduction in the relaxant effects of ANP and BNP in isolated coronary arteries in severe CHF dogs, which suggests the possibility of the downregulation of NP receptors coupled to guanylate cyclase.Keywords
This publication has 32 references indexed in Scilit:
- Increased production of nitric oxide in coronary arteries during congestive heart failure.Journal of Clinical Investigation, 1994
- Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectorisThe American Journal of Cardiology, 1993
- Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failureJournal of the American College of Cardiology, 1992
- Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)Science, 1991
- Effects of synthetic human atrial natriuretic peptide on the human coronary circulation in subjects with normal coronary arteries.Japanese Circulation Journal, 1991
- A membrane form of guanylate cyclase is an atrial natriuretic peptide receptorNature, 1989
- Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failureAmerican Heart Journal, 1988
- Down-regulation of atrial natriuretic factor receptors and correlation with cGMP stimulation in rat cultured vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1987
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Prostaglandins in Severe Congestive Heart FailureNew England Journal of Medicine, 1984